Copyright © Inderes 2011 - present. All rights reserved.
Log ind for at modtage meddelelser.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Phase Holographic Imaging PHI

1,35

 

SEK

 

+4,65 %

Mindre end 1K følgere

PHI

Spotlight Stock Market

Medical Equipment & Services

Health Care

Overview
Ownership
Investor consensus
Sammenligne
+4,65%
+1,5%
+12,97%
-17,68%
-32,5%
-83,42%
-74,14%
-95,34%
-90,49%

PHI is active in medical technology and develops both hardware and software for quantitative analysis of living cell cultures. The HoloMonitor® products are based on non-invasive QPI technology that collects data on cell quality and are sold globally through distributors with a focus on preclinical cancer research, stem cell research and drug development. Going forward, PHI focuses on developing its products for the clinical market and in regenerative medicine. PHI has offices in Lund, Boston, and Winston-Salem.

Læs mere
Markedsværdi
85,12 mio. SEK
Aktieomsætning
24,67 t SEK
Omsætning
10,51 mio.
EBIT %
-161,18 %
P/E
-
Udbytteafkast, %
-
Finanskalender
26.6
2025

Årsrapport '25

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team